BBIO — BridgeBio Pharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapMomentum Trap

Annual balance sheet for BridgeBio Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	837	472	435	681	587
Net Total Accounts Receivable
Net Total Receivables	—	—	—	4.72	139
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	889	549	478	721	798
Net Property, Plant And Equipment	46	25.2	19.8	12.8	13.5
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	1,013	623	546	919	936
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	135	121	144	154	288
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	1,883	1,878	1,901	2,387	3,023
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	-870	-1,255	-1,354	-1,468	-2,087
Total Liabilities & Shareholders' Equity	1,013	623	546	919	936
Total Common Shares Outstanding